Randal Klein
About Randal T. Klein
Randal Klein (age 60) joined XBP’s Board on July 29, 2025, as part of the post‑restructuring reconstitution; he is a Senior Portfolio Manager at Avenue Capital Management II, L.P., and a National Association of Corporate Directors Board Leadership Fellow . He holds an MBA in finance from the Wharton School and a BS in aerospace engineering from the University of Virginia; prior roles include SVP at Lehman Brothers (restructuring advisory, M&A, sponsors) and engineering/marketing at Boeing . XBP Europe Holdings, Inc. simultaneously adopted its Amended Charter and changed its name to XBP Global Holdings, Inc. on the Effective Date (July 29, 2025) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Avenue Capital Management II, L.P. | Senior Portfolio Manager | 2004–present | Oversees U.S. Strategy team investments |
| Lehman Brothers | Senior Vice President | Prior to 2004 | Restructuring advisory, sponsors coverage, M&A, corporate finance |
| The Boeing Company | Aerospace engineer; sales/marketing | Prior career start | Engineering/market roles |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Amplify Energy Corp | Director (current/past) | Not disclosed | Not disclosed |
| MagnaChip Semiconductor | Director (current/past) | Not disclosed | Not disclosed |
| GenesisCare USA Group | Director (current/past) | Not disclosed | Not disclosed |
| Gravity Oilfield Services | Director (current/past) | Not disclosed | Not disclosed |
| NextWave Holdco | Director (current/past) | Not disclosed | Not disclosed |
| Selcom Group | Director (current/past) | Not disclosed | Not disclosed |
| Chassix Automotive | Director (current/past) | Not disclosed | Not disclosed |
| Midstates Petroleum | Director (current/past) | Not disclosed | Not disclosed |
| American Media | Director (current/past) | Not disclosed | Not disclosed |
Board Governance
- Committee assignments: post‑restructuring board expanded to seven and four creditor‑designated nominees (including Klein) were appointed; specific committee assignments for new directors were not disclosed in the 8‑K .
- Pre‑restructuring committees comprised independent directors: Audit (Reynolds, Clark, Akins; Reynolds chair), Compensation (Reynolds, Clark, Akins; Clark chair), Nominating (Reynolds chair; Clark, Akins) .
- Independence: prior board determined each director other than Par Chadha and Andrej Jonovic qualified as independent under Nasdaq rules; after the restructuring XBP is no longer a “controlled company” (majority independent board expected), but independence status of newly appointed directors, including Klein, is not explicitly stated; Klein’s Avenue affiliation should be evaluated in independence determinations .
- Executive sessions: non‑management directors meet periodically in executive session without management .
- Attendance: not disclosed in the proxy or 8‑K.
Fixed Compensation
XBP’s 2024 non‑employee director compensation policy (approved January 2024) sets the baseline for director pay; specific grants to Klein were not disclosed post‑appointment.
| Component | Amount | Notes |
|---|---|---|
| Annual cash retainer | $60,000 | For board service |
| Annual equity award | $140,000 | Subject to stockholder adoption of 2024 Plan; plan later amended in July 2025 |
| Audit Committee Chair | $20,000 | Committee service fees |
| Audit Committee Member | $10,000 | Committee service fees |
| Compensation Committee Chair | $10,000 | Committee service fees |
| Compensation Committee Member | $5,000 | Committee service fees |
| Nominating Committee Chair | $8,000 | Committee service fees |
| Nominating Committee Member | $4,000 | Committee service fees |
Additional governance changes: stock plan amended to increase authorized shares (5,000,000 base; conditional to 10% of outstanding post‑restructuring), potentially affecting future director equity awards .
Performance Compensation
- No performance‑based metrics tied to director compensation were disclosed; director equity is time‑based per policy, not linked to operational KPIs .
| Performance Metric | Target/Definition | Applicability |
|---|---|---|
| Performance‑based vesting for directors | Not disclosed | No metrics disclosed |
Other Directorships & Interlocks
- Klein’s Avenue affiliation is notable given Avenue Capital’s expected post‑restructuring stake in XBP (~9.8% assuming warrant exercise), creating a shareholder‑director interlock that can influence board dynamics .
- Other major holders: Gates Capital (~25.9%) and ETI (~27.1%, assuming warrant exercise) may affect governance and voting blocs .
Expertise & Qualifications
- Distressed investing, restructuring and transaction execution experience (Avenue/Lehman) aligned with XBP’s post‑Chapter 11 capital structure needs .
- Engineering and operations background (Boeing) plus NACD Board Leadership Fellow credential support oversight in technology‑enabled services .
Equity Ownership
Direct beneficial ownership by Klein was not disclosed; Avenue’s holdings provide indirect alignment.
| Holder/Linkage | Shares/Percent | Notes |
|---|---|---|
| Avenue Capital (funds) | Expected 12,057,745–13,968,650 shares (range pre‑issuance expectation) | Post‑restructuring stake ~9.8% assuming warrants; dispersed control (no single >50%) |
| ETI | ~27.1% assuming warrant exercise | Received common stock and warrants under Plan |
| Gates Capital | ~25.9% | Significant holder post‑restructuring |
| Shares outstanding post‑issuance | 117,516,255 | Issued 81,799,821 shares under Plan |
Ownership guidelines, pledging/hedging policies for directors were not disclosed; corporate governance guidelines and Code of Ethics are posted but without specific numeric ownership requirements in the proxy .
Governance Assessment
-
Strengths:
- Board de‑staggering and move away from “controlled company” status; creditor‑designated additions bring restructuring and digital operations expertise .
- Adoption of Shareholder Rights (“poison pill”) provides near‑term takeover defense during capital structure transition; term limited to 18 months .
- Registration Rights Agreement establishes orderly liquidity path for new holders, with lock‑up coordination to support market stability .
-
Red flags / conflict considerations:
- Avenue affiliation: Klein’s role at a significant shareholder (Avenue ~9.8%) presents potential related‑party influence; independence must be assessed under Nasdaq considering this relationship .
- Creditor designation rights: four nominees, including Klein, were appointed via a one‑time creditor right; while appropriate in restructurings, this can shift board priorities toward creditor/shareholder blocs rather than minority investors .
- Complex financing stack: high secured indebtedness and multiple creditor agreements increase governance demands on audit and risk oversight committees; BPA Group’s prior material weaknesses and going‑concern issues elevate oversight risk .
- Anti‑takeover device (rights plan) may limit shareholders’ ability to realize takeover premiums, requiring clear board rationale and sunset monitoring .
-
Signals to watch:
- Committee assignments for new directors (audit/compensation/nominating) and identification of Lead Independent Director once the board finalizes roles .
- Any related‑party transactions or approvals involving Avenue/ETI/Gates; audit committee oversight of such items per charter .
- Director equity grants under the amended stock plan and any changes in cash vs. equity mix for directors post‑restructuring .
Attendance rates, individual director equity grant details (dates, share counts), and insider trading activity for Klein were not disclosed in the proxy or 8‑K documents reviewed.